Insights

Publication | Pharmaceutical Compliance Monitor

Regulatory and Compliance Implications of Orphan Drugs

November 24, 2014

Edward Buthusiem and Gary Miller write about drug development and compliance, the Orphan Drug Act, and potential program incentives.

Read the article.

Professionals

Related Professionals

Edward J. Buthusiem

Managing Director

Washington, DC